Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bakrieland Development Tbk. (ELTY) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Bakrieland Development Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Bakrieland Development Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Bakrieland Development Tbk. trades at Rp40 (market cap 1.74T, 73.26M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Bakrieland Development Tbk. is far larger — about 2.7× UBC Medical Indonesia Tbk.'s market cap, and Bakrieland Development Tbk. is more actively traded (73.26M versus 843K). Which is the better fit depends on your goals.

ELTYLABS
Market Cap
1.74T635.95B
Volume
73.26M843K
Lot
732.56K8.43K
Turnover
2.9B137.6M
Average Price
39.58163.22
Value
2.9B137.6M
Indicative Equilibrium Price
40165
Indicative Equilibrium Volume
38.05K246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ELTY
View details
LABS
View details

About Bakrieland Development Tbk.

PT Bakrieland Development Tbk. (“The Company”) was established with Notarial Deed No. 209 of John Leonard Waworuntu, S.H., dated June 12, 1990. The Company's articles of association have been amended several times, among others, the changes of the Company's name from PT Elang Realty (formerly PT. Purilestari Indah Pratama) Tbk. to PT Bakrieland Development Tbk. which have been notarized by Notarial Deed No. 29 of Harun Kamil, S.H., dated April 3, 1997.

Read more on ELTY

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS